Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Journal of Neurology|April 28, 2025
Long-term neuropsychological consequences of severe COVID-19 infection: the NEUROCOG-COVID studyMylène Meyer, Thérèse Jonveaux, Claire Banasiak, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 12, 2018
Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stageOlivier Bousiges, Stephanie Bombois, Susanna Schraen, et al.
Journal of Neurology|September 26, 2012
Logopenic syndrome in posterior cortical atrophyEloi Magnin, Geraldine Sylvestre, Flora Lenoir, et al.
Clinical Medicine Insights. Oncology|August 26, 2016
Age, Neurological Status MRC Scale, and Postoperative Morbidity are Prognostic Factors in Patients with Glioblastoma Treated by ChemoradiotherapyClotilde Verlut, Guillaume Mouillet, Eloi Magnin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2020
Cerebrospinal Fluid Levels of Kininogen-1 Indicate Early Cognitive Impairment in Parkinson's DiseaseIoanna Markaki, Sofia Bergström, Panagiota Tsitsi, et al.
Journal of Neurology|October 29, 2013
Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric studyFrançois Mouton-Liger, David Wallon, Anne-Cécile Troussière, et al.
Alzheimer'S Research & Therapy|July 1, 2016
Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective studyClaire Paquet, Eloi Magnin, David Wallon, et al.
Journal of Alzheimer'S Disease : JAD|February 22, 2020
Cerebrospinal Fluid and Plasma Biomarkers do not Differ in the Presenile and Late-Onset Behavioral Variants of Frontotemporal DementiaCecilia Marelli, Claire Hourregue, Laure-Anne Gutierrez, et al.
European Journal of Neurology|August 4, 2025
Neurodevelopmental Vulnerability in Alzheimer's Disease and Frontotemporal DementiaPerrine Laury Marie Siguier, Mélanie Planton, Bérengère Pages, et al.
Pageof 8